Altered expression of drug metabolizing enzymes, such as UGT1A, UGT2B, SULT1C[24], NAT2[25] and GSTO[26] have been reportedly associated with intrahepatic cholangiocarcinoma in endemic area of liver fluke infection. This evidence concerns the gene NAT2 and intrahepatic cholangiocarcinoma.